Clonal Analysis of Progenitor Activities During Native and Transplant Hematopoiesis

天然和移植造血过程中祖细胞活性的克隆分析

• 批准号: 9087944
• 负责人: Jianlong Sun
• 金额: $ 15.19万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-05 至 2021-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9087944
• 关键词: Address; Affect; Behavior; Biological Assay; Blood; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Cell Lineage; Cell Proliferation; Cell Survival; Cell physiology; Cells; Gene Expression Profile; Generations; Genetic; Goals; Hematopoiesis; Hematopoietic; Hematopoietic stem cells; Homeostasis; In Situ; Investigational Therapies; Label; Longevity; Maintenance; Measures; Mediating; Modeling; Molecular; Molecular Biology; Mus; Natural regeneration; Outcome; Output; Play; Population; Population Dynamics; Population Heterogeneity; Process; Production; Property; Regulation; Research; Role; Staging; Stem cells; Stress; System; Techniques; Technology; Testing; Time; Tissues; Transplant Recipients; Transplantation; Work; base; cell type; cytotoxic; design; dynamic system; exhaust; exhaustion; experience; improved; in vivo; insight; neglect; non-Native; novel; peripheral blood; premature; primitive cell; progenitor; public health relevance; self-renewal; stem; tool

 DESCRIPTION (provided by applicant): Blood is a highly dynamic system, in which billions of mature cells are replenished every day. It is traditionally thought that this ongoing process of cel regeneration exclusively depends on hematopoietic stem cells (HSC); whereas progenitors, the abundant progeny of HSCs, are generally thought to represent transient amplifying stages, where rare primitive cells are dramatically expanded before the final production of functional blood cells. While the essential role of HSC in blood regeneration has been repeatedly demonstrated in both experimental and therapeutic transplantation, recent studies using novel in situ lineage tracing techniques have revealed very limited contribution of HSC to blood cell generation at steady state under native, unperturbed conditions. In contrast, the progenitor populations, although non-transplantable, have a much more persistent ability for blood generation during native hematopoiesis. These findings collectively demonstrate a previously unappreciated level of regulation of blood homeostasis at the stage of progenitor cells. They also highlight the potential use of progenitors for robust hematolymphoid regeneration during bone marrow transplantation. This proposal aims to further characterize the cellular and molecular mechanisms by which the progenitors sustain their long-term in vivo hematopoietic activities. Aim 1 will attempt to elucidate the contribution by the different subsets of the progenitors in ongoing blood cell production. This will be achieved by comparing clonal overlapping between different blood lineages, and also by directly measuring the clonal output of the progenitor subsets at multiple time points following induction of transposon labeling. In Aim 2, the clonal complexity and clone size of progenitors will be examined at different stages of the mouse lifespan. Results of this analysis will help to determine if progenitor self-renewal is achieved at the level of single cells, or is accomplished through population dynamics. The role of cellular dormancy in preserving progenitor activity, and molecular basis of distinct clonal behaviors will be explored as well in this aspect of the study. Aim 3 will focus on the impact of bone marrow transplantation on functional properties of progenitors. The H2B-GFP label-retaining model will be used to test the global impact of transplantation on progenitor proliferation and survival. And the transposon technology will help compare the clonal behaviors of progenitors in self-renewal and differentiation during native and transplant hematopoiesis. In the aggregate, these proposed studies will bring new insights to the old questions of cellular mechanisms of blood regeneration. Outcomes of the proposed work may also provide clues for the design of better strategies for preserving progenitor activity during transplantation.

 描述（申请人提供）：血液是一个高度动态的系统，其中每天补充数十亿个成熟细胞。传统上认为，这种正在进行的细胞再生过程完全依赖于造血干细胞（HSC）;而祖细胞（HSC的丰富后代）通常被认为代表短暂的扩增阶段，其中罕见的原始细胞在最终产生功能性血细胞之前急剧扩增。虽然HSC在血液再生中的重要作用已在实验性和治疗性移植中反复证明，但最近使用新型原位谱系追踪技术的研究揭示了在天然未受干扰的条件下，HSC对稳态血细胞生成的贡献非常有限。相比之下，祖细胞群体虽然不可移植，但在天然造血过程中具有更持久的血液生成能力。这些发现共同证明了在祖细胞阶段血液稳态调节的先前未被重视的水平。他们还强调了在骨髓移植过程中祖细胞在强大的血淋巴细胞再生中的潜在用途。该建议旨在进一步表征祖细胞维持其长期体内造血活性的细胞和分子机制。目的1将试图阐明祖细胞的不同亚群在进行中的血细胞产生中的贡献。这将通过比较不同血液谱系之间的克隆重叠，以及通过在转座子标记诱导后的多个时间点直接测量祖细胞亚群的克隆输出来实现。在目标2中，将在小鼠寿命的不同阶段检查祖细胞的克隆复杂性和克隆大小。这种分析的结果将有助于确定祖细胞自我更新是在单细胞水平上实现的，还是通过群体动力学实现的。细胞休眠在保持祖细胞活性中的作用，以及不同克隆行为的分子基础也将在这方面的研究中进行探索。目的3将关注骨髓移植对祖细胞功能特性的影响。H2 B-GFP标记保留模型将用于测试移植对祖细胞增殖和存活的总体影响。转座子技术将有助于比较原始造血和移植造血过程中祖细胞自我更新和分化的克隆行为。总的来说，这些拟议的研究将为血液再生的细胞机制的老问题带来新的见解。这项工作的结果也可能为设计更好的策略提供线索，以在移植过程中保留祖细胞活性。